Pharmacophore modeling, molecular docking and molecular dynamics studies on natural products database to discover novel skeleton as non-purine xanthine oxidase inhibitors
- 4 May 2018
- journal article
- research article
- Published by Taylor & Francis in Journal of Receptors and Signal Transduction
- Vol. 38 (3) , 246-255
Abstract
Gout is a common inflammatory arthritis caused by the deposition of urate crystals within joints. It is increasingly in prevalence during the past few decades as shown by the epidemiological survey results. Xanthine oxidase (XO) is a key enzyme to transfer hypoxanthine and xanthine to uric acid, whose overproduction leads to gout. Therefore, inhibiting the activity of xanthine oxidase is an important way to reduce the production of urate. In the study, in order to identify the potential natural products targeting XO, pharmacophore modeling was employed to filter databases. Here, two methods, pharmacophore based on ligand and pharmacophore based on receptor-ligand, were constructed by Discovery Studio. Then GOLD was used to refine the potential compounds with higher fitness scores. Finally, molecular docking and dynamics simulations were employed to analyze the interactions between compounds and protein. The best hypothesis was set as a 3D query to screen database, returning 785 and 297 compounds respectively. A merged set of the above 1082 molecules was subjected to molecular docking, which returned 144 hits with high-fitness scores. These molecules were clustered in four main kinds depending on different backbones. What is more, molecular docking showed that the representative compounds established key interactions with the amino acid residues in the protein, and the RMSD and RMSF of molecular dynamics results showed that these compounds can stabilize the protein. The information represented in the study confirmed previous reports. And it may assist to discover and design new backbones as potential XO inhibitors based on natural products.Keywords
Funding Information
- CAS "Light of west China" program
- CAS Strategic biological resources service network (ZSTH-021)
- the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA12030206)
- Science, and National Natural Science Foundation of China (21772207)
This publication has 44 references indexed in Scilit:
- Prevalence and associations of gout and hyperuricaemia: results from an Australian population‐based studyInternal Medicine Journal, 2016
- Rising burden of gout in the UK but continuing suboptimal management: a nationwide population studyAnnals of the Rheumatic Diseases, 2015
- Epidemiology of GoutRheumatic Disease Clinics of North America, 2014
- The Mononuclear Molybdenum EnzymesChemical Reviews, 2014
- GoutNew England Journal of Medicine, 2011
- Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of AllopurinolPharmacological Reviews, 2006
- Y-700 [1-[3-Cyano-4-(2,2-dimethylpropoxy)phenyl]-1 H-pyrazole-4-carboxylic Acid]: A Potent Xanthine Oxidoreductase Inhibitor with Hepatic ExcretionThe Journal of Pharmacology and Experimental Therapeutics, 2004
- The crystal structure of xanthine oxidoreductase during catalysis: Implications for reaction mechanism and enzyme inhibitionProceedings of the National Academy of Sciences, 2004
- An Extremely Potent Inhibitor of Xanthine OxidoreductaseJournal of Biological Chemistry, 2003
- Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: Structure-based mechanism of conversionProceedings of the National Academy of Sciences, 2000